Artivion(AORT)
KENNESAW, GABiotechnology
Focus: Artivion is a publicly traded medical device and tissue engineering company focused on cardiovascular solutions, including surgical devices, allograft tissues, and hemostatic systems. With ~$354M in revenue (FY2025) and 1,001–5,000 employees, it operates as a specialized cardiovascular device manufacturer.
Profile data last refreshed 17h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
About Artivion
AI assessmentNot HiringNo open roles listed right now. Follow Artivion to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Artivion's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$354M
Pipeline & Clinical Trials
N/A
Clinical Trials (2)
NCT03397251DARTS I: Feasibility, Safety, and Performance Trial
N/AHelp build intelligence for Artivion
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.